Sonoma Pharmaceuticals (SNOA) Debt Ratio (2011 - 2025)

Sonoma Pharmaceuticals' Debt Ratio history runs 15 years deep, the most recent figure standing at 0.0 for Q3 2025.

• In Q3 2025, Debt Ratio fell 32.55% year-over-year to 0.0; the TTM figure through Sep 2025 stood at 0.0 (down 32.55% YoY), while the FY2025 annual figure was 0.02, down 26.68% from the prior year.
• Debt Ratio was 0.0 for Q3 2025 at Sonoma Pharmaceuticals, down from 0.01 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.13 in Q1 2021 to a low of 0.0 in Q4 2022.
• Historically, Debt Ratio has averaged 0.02 across 5 years, with a median of 0.02 in 2025.
• Biggest YoY gain for Debt Ratio was 284.99% in 2021; the steepest drop was 86.6% in 2021.
• A 5-year view of Debt Ratio shows it stood at 0.01 in 2021, then plunged by 89.27% to 0.0 in 2022, then soared by 179.49% to 0.0 in 2023, then surged by 99.07% to 0.01 in 2024, then tumbled by 32.55% to 0.0 in 2025.
• The last three Debt Ratio figures came in at 0.0 (Q3 2025), 0.01 (Q2 2025), and 0.02 (Q1 2025), per Business Quant data.